$VPHM Headlines Morgan Stanley drops Google from
Post# of 5326
Posted On: 11/18/2013 8:21:45 PM
$VPHM Headlines
Morgan Stanley drops Google from best idea list 4:25 p.m. Nov. 11, 2013 - Sue Chang
Shire up in London; BSkyB, ITV off after BT soccer deal 12:10 p.m. Nov. 11, 2013 - Sara Sjolin
Strong Chinese data lift European markets 12:09 p.m. Nov. 11, 2013 - Sara Sjolin
Stock futures higher; Twitter, ViroPhama in spotlight 7:54 a.m. Nov. 11, 2013 - Barbara Kollmeyer
ViroPharma surges 26.5% premarket on Shire buyout 7:27 a.m. Nov. 11, 2013 - Ben Eisen
Shire pays $4.2B for rare-disease firm ViroPharma 2:54 a.m. Nov. 11, 2013 - MarketWatch.com
Powerful market uptrend meets seasonal tailwind 11:11 a.m. Nov. 1, 2013 - Michael Ashbaugh
ViroPharma shares soar on news of interest from two overseas buyers 5:09 p.m. Sept. 13, 2013 - Russ Britt
S&P 500 retests its one-decade breakout point 10:37 a.m. June 24, 2013 - Michael Ashbaugh
ViroPharma soars on buyout rumors 1:27 p.m. June 17, 2013 - Russ Britt
Market post-mortem: Big biotechs spike as Street warming to firms 4:43 p.m. April 12, 2013 - Russ Britt
Blood disease medication earns ViroPharma upbeat analyst reviews 12:43 p.m. March 27, 2013 - Russ Britt
Ratings hit three health firms; upgrade helps one 6:12 p.m. Jan. 15, 2013 - Russ Britt
Friday’s biggest gaining and declining stocks 3:14 p.m. Sept. 21, 2012 - Greg Morcroft
ViroPharma gets okay to test reformulated Cinryze 12:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 10:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 7:30 a.m. Sept. 21, 2012 - MarketWatch.com
ViroPharma up 15% on FDA nod 2:25 p.m. Aug. 6, 2012 - Val Brickates Kennedy
ViroPharma has FDA nod to expand Cinryze 1:19 p.m. Aug. 6, 2012 - MarketWatch.com
Knight Capital, E-Trade options volumes soar 10:06 a.m. Aug. 2, 2012 - blogs.marketwatch.com
Medicines Co. Gains on QIDP Status - Analyst Blog 1:10 p.m. Nov. 14, 2013 - Zacks.com
Shire PLC Makes For A Promising Investment 12:52 p.m. Nov. 13, 2013 - Seeking Alpha
Shire to Acquire ViroPharma - Analyst Blog 3:53 p.m. Nov. 12, 2013 - Zacks.com
Shire Acquires Viropharma: Two Winners In This Deal 12:55 p.m. Nov. 12, 2013 - Seeking Alpha
Stock Market News for November 12, 2013 - Market News 10:06 a.m. Nov. 12, 2013 - Zacks.com
UPDATE: J.P. Morgan Downgrades ViroPharma Following Announcement of Acquisition by Shire 9:40 a.m. Nov. 12, 2013 - benzinga.com
Benzinga's M&A Chatter for Monday November 11, 2013 5:31 p.m. Nov. 11, 2013 - benzinga.com
ViroPharma Larger Than S&P 500 Component JDS Uniphase 4:39 p.m. Nov. 11, 2013 - TheStreet.com
Shire Buying ViroPharma To Rule Rare Disease Market 4:18 p.m. Nov. 11, 2013 - Investors Business Daily
ViroPharma Gets Bought Out; Medicines Clears Entry 4:13 p.m. Nov. 11, 2013 - Investors Business Daily
Intel Buys ‘Kno’ to Reinforce Education Laptops Sideline and 2 Other Hot Stocks to Watch 11:35 a.m. Nov. 11, 2013 - Wall St. Cheat Sheet
Shire's Growth Carries Swollen Price Tag 11:27 a.m. Nov. 11, 2013 - WSJ.com
Shire Acquiring ViroPharma; Both Stocks Hit Highs 9:57 a.m. Nov. 11, 2013 - Investors Business Daily
Mid-Morning Market Update: Markets Edge Higher; Shire To Acquire ViroPharma For $4.2B 9:37 a.m. Nov. 11, 2013 - benzinga.com
Shire Shells Out $4.2B to Buy ViroPharma 9:15 a.m. Nov. 11, 2013 - FOXBusiness
Morning Market Movers 9:11 a.m. Nov. 11, 2013 - benzinga.com
Shire Buys ViroPharma for $4.2 Billion 8:02 a.m. Nov. 11, 2013 - WSJ.com
Today's Pre-Market Mover With Heavy Volume: ViroPharma (VPHM) 7:48 a.m. Nov. 11, 2013 - TheStreet.com
Shire, Novartis Deals: Pharmaceutical Shakeups Continue 6:55 a.m. Nov. 11, 2013 - 247WallSt.com
Wall Street Breakfast: Must-Know News 6:34 a.m. Nov. 11, 2013 - Seeking Alpha
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of ViroPharma, Inc. 6:14 p.m. Nov. 14, 2013 - BusinessWire
Acquisitions, Clinical Trial Results and Stock Price Movements - Research Report on ViroPharma, Pfizer, Alkermes, Tenet, and ResMed 8:00 a.m. Nov. 14, 2013 - PR Newswire
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of ViroPharma Incorporated Stockholders 5:11 p.m. Nov. 13, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of ViroPharma, Inc. - VPHM 3:15 p.m. Nov. 13, 2013 - PR Newswire
VIROPHARMA INCORPORATED SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:57 a.m. Nov. 13, 2013 - BusinessWire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of ViroPharma, Inc. - VPHM 8:28 p.m. Nov. 12, 2013 - PR Newswire
Attention VPHM Shareholders: The Proposed Buyout of ViroPharma Incorporated by Shire plc is under Investigation by The Young Law Firm 1:00 p.m. Nov. 12, 2013 - BusinessWire
LEVI & KORSINSKY, LLP Investigates VIROPHARMA, INC. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC 12:53 p.m. Nov. 12, 2013 - BusinessWire
Ryan & Maniskas, LLP Announces Investigation of ViroPharma Inc. 10:49 a.m. Nov. 12, 2013 - PR Newswire
FDA Updates, Corporate Developments: Viropharma, 3D Systems Corporation, Cirrus Logic, Zalicus, The Boeing Company 8:53 a.m. Nov. 12, 2013 - PR Newswire
Analysis of Pivotal Study Data Showed Routine Prevention of Hereditary Angioedema (HAE) Attacks with Cinryze® (C1 esterase inhibitor [human]) Resulted in Improved Health-Related Quality of Life Outcomes Compared to Acute Therapy with C1 Inhibitor While On Placebo 8:00 a.m. Nov. 12, 2013 - PR Newswire
Harwood Feffer LLP Announces Investigation of ViroPharma, Inc. 5:24 p.m. Nov. 11, 2013 - PR Newswire
SHAREHOLDER ALERT: Law Firm Brower Piven Announces Investigation of Possible Breaches of Fiduciary Duty by Directors of ViroPharma Incorporated in Connection with Proposed Buyout 4:09 p.m. Nov. 11, 2013 - BusinessWire
Finkelstein Thompson LLP Announces Investigation of ViroPharma Inc. Buyout Proposal 3:23 p.m. Nov. 11, 2013 - BusinessWire
VIROPHARMA INCORPORATED SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2:33 p.m. Nov. 11, 2013 - BusinessWire
ViroPharma Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Shire 12:17 p.m. Nov. 11, 2013 - BusinessWire
LEVI & KORSINSKY, LLP Investigates VIROPHARMA, INC. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC 11:15 a.m. Nov. 11, 2013 - BusinessWire
VIROPHARMA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of ViroPharma Inc. (VPHM) Over the Proposed Sale of the Company to Shire (SHPG) in a Cash Deal 11:14 a.m. Nov. 11, 2013 - BusinessWire
Law Firm Brower Piven Announces Investigation of ViroPharma Incorporated Proposed Buyout 11:08 a.m. Nov. 11, 2013 - BusinessWire
Morgan Stanley drops Google from best idea list 4:25 p.m. Nov. 11, 2013 - Sue Chang
Shire up in London; BSkyB, ITV off after BT soccer deal 12:10 p.m. Nov. 11, 2013 - Sara Sjolin
Strong Chinese data lift European markets 12:09 p.m. Nov. 11, 2013 - Sara Sjolin
Stock futures higher; Twitter, ViroPhama in spotlight 7:54 a.m. Nov. 11, 2013 - Barbara Kollmeyer
ViroPharma surges 26.5% premarket on Shire buyout 7:27 a.m. Nov. 11, 2013 - Ben Eisen
Shire pays $4.2B for rare-disease firm ViroPharma 2:54 a.m. Nov. 11, 2013 - MarketWatch.com
Powerful market uptrend meets seasonal tailwind 11:11 a.m. Nov. 1, 2013 - Michael Ashbaugh
ViroPharma shares soar on news of interest from two overseas buyers 5:09 p.m. Sept. 13, 2013 - Russ Britt
S&P 500 retests its one-decade breakout point 10:37 a.m. June 24, 2013 - Michael Ashbaugh
ViroPharma soars on buyout rumors 1:27 p.m. June 17, 2013 - Russ Britt
Market post-mortem: Big biotechs spike as Street warming to firms 4:43 p.m. April 12, 2013 - Russ Britt
Blood disease medication earns ViroPharma upbeat analyst reviews 12:43 p.m. March 27, 2013 - Russ Britt
Ratings hit three health firms; upgrade helps one 6:12 p.m. Jan. 15, 2013 - Russ Britt
Friday’s biggest gaining and declining stocks 3:14 p.m. Sept. 21, 2012 - Greg Morcroft
ViroPharma gets okay to test reformulated Cinryze 12:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 10:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 7:30 a.m. Sept. 21, 2012 - MarketWatch.com
ViroPharma up 15% on FDA nod 2:25 p.m. Aug. 6, 2012 - Val Brickates Kennedy
ViroPharma has FDA nod to expand Cinryze 1:19 p.m. Aug. 6, 2012 - MarketWatch.com
Knight Capital, E-Trade options volumes soar 10:06 a.m. Aug. 2, 2012 - blogs.marketwatch.com
Medicines Co. Gains on QIDP Status - Analyst Blog 1:10 p.m. Nov. 14, 2013 - Zacks.com
Shire PLC Makes For A Promising Investment 12:52 p.m. Nov. 13, 2013 - Seeking Alpha
Shire to Acquire ViroPharma - Analyst Blog 3:53 p.m. Nov. 12, 2013 - Zacks.com
Shire Acquires Viropharma: Two Winners In This Deal 12:55 p.m. Nov. 12, 2013 - Seeking Alpha
Stock Market News for November 12, 2013 - Market News 10:06 a.m. Nov. 12, 2013 - Zacks.com
UPDATE: J.P. Morgan Downgrades ViroPharma Following Announcement of Acquisition by Shire 9:40 a.m. Nov. 12, 2013 - benzinga.com
Benzinga's M&A Chatter for Monday November 11, 2013 5:31 p.m. Nov. 11, 2013 - benzinga.com
ViroPharma Larger Than S&P 500 Component JDS Uniphase 4:39 p.m. Nov. 11, 2013 - TheStreet.com
Shire Buying ViroPharma To Rule Rare Disease Market 4:18 p.m. Nov. 11, 2013 - Investors Business Daily
ViroPharma Gets Bought Out; Medicines Clears Entry 4:13 p.m. Nov. 11, 2013 - Investors Business Daily
Intel Buys ‘Kno’ to Reinforce Education Laptops Sideline and 2 Other Hot Stocks to Watch 11:35 a.m. Nov. 11, 2013 - Wall St. Cheat Sheet
Shire's Growth Carries Swollen Price Tag 11:27 a.m. Nov. 11, 2013 - WSJ.com
Shire Acquiring ViroPharma; Both Stocks Hit Highs 9:57 a.m. Nov. 11, 2013 - Investors Business Daily
Mid-Morning Market Update: Markets Edge Higher; Shire To Acquire ViroPharma For $4.2B 9:37 a.m. Nov. 11, 2013 - benzinga.com
Shire Shells Out $4.2B to Buy ViroPharma 9:15 a.m. Nov. 11, 2013 - FOXBusiness
Morning Market Movers 9:11 a.m. Nov. 11, 2013 - benzinga.com
Shire Buys ViroPharma for $4.2 Billion 8:02 a.m. Nov. 11, 2013 - WSJ.com
Today's Pre-Market Mover With Heavy Volume: ViroPharma (VPHM) 7:48 a.m. Nov. 11, 2013 - TheStreet.com
Shire, Novartis Deals: Pharmaceutical Shakeups Continue 6:55 a.m. Nov. 11, 2013 - 247WallSt.com
Wall Street Breakfast: Must-Know News 6:34 a.m. Nov. 11, 2013 - Seeking Alpha
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of ViroPharma, Inc. 6:14 p.m. Nov. 14, 2013 - BusinessWire
Acquisitions, Clinical Trial Results and Stock Price Movements - Research Report on ViroPharma, Pfizer, Alkermes, Tenet, and ResMed 8:00 a.m. Nov. 14, 2013 - PR Newswire
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of ViroPharma Incorporated Stockholders 5:11 p.m. Nov. 13, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of ViroPharma, Inc. - VPHM 3:15 p.m. Nov. 13, 2013 - PR Newswire
VIROPHARMA INCORPORATED SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:57 a.m. Nov. 13, 2013 - BusinessWire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of ViroPharma, Inc. - VPHM 8:28 p.m. Nov. 12, 2013 - PR Newswire
Attention VPHM Shareholders: The Proposed Buyout of ViroPharma Incorporated by Shire plc is under Investigation by The Young Law Firm 1:00 p.m. Nov. 12, 2013 - BusinessWire
LEVI & KORSINSKY, LLP Investigates VIROPHARMA, INC. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC 12:53 p.m. Nov. 12, 2013 - BusinessWire
Ryan & Maniskas, LLP Announces Investigation of ViroPharma Inc. 10:49 a.m. Nov. 12, 2013 - PR Newswire
FDA Updates, Corporate Developments: Viropharma, 3D Systems Corporation, Cirrus Logic, Zalicus, The Boeing Company 8:53 a.m. Nov. 12, 2013 - PR Newswire
Analysis of Pivotal Study Data Showed Routine Prevention of Hereditary Angioedema (HAE) Attacks with Cinryze® (C1 esterase inhibitor [human]) Resulted in Improved Health-Related Quality of Life Outcomes Compared to Acute Therapy with C1 Inhibitor While On Placebo 8:00 a.m. Nov. 12, 2013 - PR Newswire
Harwood Feffer LLP Announces Investigation of ViroPharma, Inc. 5:24 p.m. Nov. 11, 2013 - PR Newswire
SHAREHOLDER ALERT: Law Firm Brower Piven Announces Investigation of Possible Breaches of Fiduciary Duty by Directors of ViroPharma Incorporated in Connection with Proposed Buyout 4:09 p.m. Nov. 11, 2013 - BusinessWire
Finkelstein Thompson LLP Announces Investigation of ViroPharma Inc. Buyout Proposal 3:23 p.m. Nov. 11, 2013 - BusinessWire
VIROPHARMA INCORPORATED SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2:33 p.m. Nov. 11, 2013 - BusinessWire
ViroPharma Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Shire 12:17 p.m. Nov. 11, 2013 - BusinessWire
LEVI & KORSINSKY, LLP Investigates VIROPHARMA, INC. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC 11:15 a.m. Nov. 11, 2013 - BusinessWire
VIROPHARMA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of ViroPharma Inc. (VPHM) Over the Proposed Sale of the Company to Shire (SHPG) in a Cash Deal 11:14 a.m. Nov. 11, 2013 - BusinessWire
Law Firm Brower Piven Announces Investigation of ViroPharma Incorporated Proposed Buyout 11:08 a.m. Nov. 11, 2013 - BusinessWire
(0)
(0)